648 related articles for article (PubMed ID: 26888806)
21. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
[TBL] [Abstract][Full Text] [Related]
22. Platelet counts on admission affect coronary flow, myocardial perfusion and left ventricular systolic function after primary percutaneous coronary intervention.
Sharif D; Abu-Salem M; Sharif-Rasslan A; Rosenschein U
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):632-639. PubMed ID: 27069068
[TBL] [Abstract][Full Text] [Related]
23. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial).
Dohi T; Maehara A; Brener SJ; Généreux P; Gershlick AH; Mehran R; Gibson CM; Mintz GS; Stone GW
Am J Cardiol; 2015 Mar; 115(5):563-70. PubMed ID: 25586335
[TBL] [Abstract][Full Text] [Related]
24. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
25. A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
Geng W; Zhang Q; Liu J; Tian X; Zhen L; Song D; Yang Y; Meng H; Wang Y; Chen J
J Interv Cardiol; 2018 Apr; 31(2):136-143. PubMed ID: 29171086
[TBL] [Abstract][Full Text] [Related]
26. [Efficiency and safety of thrombus aspiration plus intra-infarct-related artery administration of tirofiban during primary angioplasty].
Li SY; Yan HB; Wang J; Song L; Wu Z; Chi YP; Zheng B; Zhao HJ; Li QX; Zhang XJ; Li WZ; Liu C
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Oct; 38(10):880-5. PubMed ID: 21176629
[TBL] [Abstract][Full Text] [Related]
27. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
[TBL] [Abstract][Full Text] [Related]
28. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
29. Effects of recombinant human brain natriuretic peptide on renal function in patients with acute heart failure following myocardial infarction.
Wang Y; Gu X; Fan W; Fan Y; Li W; Fu X
Am J Transl Res; 2016; 8(1):239-45. PubMed ID: 27069557
[TBL] [Abstract][Full Text] [Related]
30. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
[TBL] [Abstract][Full Text] [Related]
31. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
[TBL] [Abstract][Full Text] [Related]
32. Influence of recombinant human B-type natriuretic peptide on improving ventricular function in patients with ST elevation myocardial infarction.
Yao L; Liu CJ; Zhang L; Lin Y; Hu YM
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3420-3429. PubMed ID: 37140291
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic effect of urapidil on myocardial perfusion in patients with ST-elevation acute coronary syndrome.
Yao DK; Jia SQ; Wang L; Li HW; Zhang YC; Wang YL; Wang LX
Eur J Intern Med; 2009 Mar; 20(2):152-7. PubMed ID: 19327603
[TBL] [Abstract][Full Text] [Related]
34. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Ocek AH
Coron Artery Dis; 2014 Mar; 25(2):159-66. PubMed ID: 24326783
[TBL] [Abstract][Full Text] [Related]
35. Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplasty.
Lupi A; Rognoni A; Cavallino C; Secco GG; Reale D; Cossa G; Rosso R; Bongo AS; Cortese B; Angiolillo DJ; Jaffe AS; Porto I
Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):487-96. PubMed ID: 26163529
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of the effects of intravenous recombinant human brain natriuretic peptide and nitroglycerin in patients with decompensated acute heart failure: a multicenter, randomized, open-label, parallel-design study].
Recombinant Human Brain Natriuretic Peptide Study Group
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):222-6. PubMed ID: 16630454
[TBL] [Abstract][Full Text] [Related]
37. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
[TBL] [Abstract][Full Text] [Related]
38. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
[TBL] [Abstract][Full Text] [Related]
39. Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients.
Zhang J; Ding G
Evid Based Complement Alternat Med; 2021; 2021():8371996. PubMed ID: 34221091
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
